Diabetes Care, Vol 15, Issue 7 908-911, Copyright © 1992 by American Diabetes Association

ARTICLES

Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients

D Ziegler, K Dannehl, D Volksw, H Muhlen, M Spuler and FA Gries
Diabetes Research Institute, Heinrich-Heine-University, Dusseldorf, Germany.

OBJECTIVE--To determine the prevalence of cardiovascular autonomic nerve dysfunction in patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM) compared with healthy nondiabetic subjects. RESEARCH DESIGN AND METHODS--A battery of cardiovascular reflex tests was performed in 130 newly diagnosed IDDM patients aged 12-40 yr at mean blood glucose levels of 7.2 mM after insulin had been administered for 3-39 days. Age-dependent lower limits of normal of these tests were defined at the 2.3 percentile in 120 nondiabetic subjects. Tests of heart-rate variation (HRV) included the coefficient of variation (C.V.) and the low-frequency (LF), midfrequency (MF), and high-frequency (HF) bands of spectral analysis at rest, HRV during deep breathing (C.V., expiratory-inspiratory ratio, and mean circular resultant), Valsalva ratio, and maximum/minimum 30:15 ratio. In addition, spectral analysis on standing, the change in systolic blood pressure to standing, and diastolic blood pressure response to sustained handgrip were determined in 50 patients. RESULTS--A significantly higher percentage of abnormal test responses in the diabetic group compared with the control group was noted for power spectrum in the LF band (7.3 vs. 0.8%, P less than 0.05) and MF band (10.6 vs. 0%, P less than 0.001) at rest and HF band on standing (10.0 vs. 0.9%, P less than 0.05), maximum/minimum 30:15 ratio (25.4 vs. 5.0%, P less than 0.001), and Valsalva ratio (17.5 vs. 4.2%, P less than 0.001). There were no significant differences between both groups in regard to the remaining parameters. Ten (7.7%) diabetic patients but none of the nondiabetic subjects had cardiovascular autonomic neuropathy defined by the strict criterion of abnormal results in more than three of six tests (P less than 0.001). In addition, 12 (9.2%) patients but only 2 (1.7%) control subjects had abnormal results in two of six tests (P less than 0.01). CONCLUSIONS--Cardiovascular autonomic nerve dysfunction is relatively common in newly diagnosed IDDM patients after correction of the initial metabolic imbalance. A combination of tests based on spectral and conventional analysis of HRV appears suitable for detection of early abnormalities in autonomic function in diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Jirkovska, P. Boucek, S. Wu, J. Hosova, R. Bem, V. Fejfarova, and J. Skibova Power Spectral Analysis of Heart Rate Variability in Patients with Charcot's Neuroarthropathy J Am Podiatr Med Assoc, January 1, 2006; 96(1): 1 - 8. [Abstract] [Full Text] [PDF]

				M. S. Faulkner, L. Quinn, J. H. Rimmer, and B. H. Rich Cardiovascular Endurance and Heart Rate Variability in Adolescents With Type 1 or Type 2 Diabetes Biol Res Nurs, July 1, 2005; 7(1): 16 - 29. [Abstract] [PDF]

				K. Keresztes, I. Istenes, Z. Hermanyi, P. Vargha, I. Barna, and P. Kempler Risk Factors of Autonomic and Sensory Nerve Dysfunction in Patients With Newly Diagnosed Type 1 Diabetes Diabetes Care, July 1, 2003; 26(7): 2213 - 2214. [Full Text] [PDF]

				D. Pittasch, R. Lobmann, W. Behrens-Baumann, and H. Lehnert Pupil Signs of Sympathetic Autonomic Neuropathy in Patients With Type 1 Diabetes Diabetes Care, September 1, 2002; 25(9): 1545 - 1550. [Abstract] [Full Text] [PDF]

				D. K. Hathaway, M. N. Wicks, A. K. Cashion, P. A. Cowan, E. J. Milstead, and A. O. Gaber Posttransplant Improvement in Heart Rate Variability Correlates with Improved Quality of Life West J Nurs Res, October 1, 2000; 22(6): 749 - 768. [Abstract] [PDF]

				R. D. Hoeldtke, K. D. Bryner, G. R. Hobbs, G. G. Horvath, J. E. Riggs, I. Christie, G. Ganser, S. M. Marcovina, and A. Lernmark Antibodies to Glutamic Acid Decarboxylase and Peripheral Nerve Function in Type 1 Diabetes J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3297 - 3308. [Abstract] [Full Text]

				R. D. Hoeldtke, K. D. Bryner, P. Komanduri, I. Christie, G. Ganser, and G. R. Hobbs Decreased Prorenin Processing Develops before Autonomic Dysfunction in Type 1 Diabetes J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 585 - 589. [Abstract] [Full Text]